Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTFC vs BTFC 24-hour IOP Control in POAG
NCT00972257Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Jan 2009
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dorzolamide + timolol, brimonidine tartrate + timolol maleate in primary open-angle glaucoma (POAG), sponsored by Aristotle University of Thessaloniki. Started Jan 2009; status: completed.
02
Drugs
dorzolamide + timololbrimonidine tartrate + timolol maleate
03
Conditions
primary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT00972257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00972257.